Foghorn Therapeutics Inc. Common Stock

FHTXNASDAQ • USD
ThemeBiotech - Drug Development›Clinical-Stage Platforms
4.17 USD
↗ 0.05 (1.21%)AT CLOSE (11:59 AM EDT)
4.16
↘ 0.01 (0.36%)
POST MARKET (AS OF 04:15 PM EDT)
Post Market
AS OF 04:15 PM EDT
4.16
↘ 0.01 (0.36%)
🟢Market: OPEN

Foghorn Therapeutics Inc. Common Stock (FHTX) trades at $4.16 per share. Both sides of the analysis point lower: technicals flash "Strong Sell" and fundamentals confirm with a "Sell" reading. Notable factors include a concerning Altman Z-Score in the distress zone, exceptional Return on Equity (79.7%) and a bullish Golden Cross on the moving averages. Valuation metrics place FHTX at a fair price relative to peers.

Technical & fundamental data as of Sep 16, 2026.

Open?$4.17
High?$4.23
Low?$4.08
Prev. Close?$4.12
Volume?354.9K
Avg. Volume?362.6K
VWAP?$4.16
Rel. Volume?0.98x
Bid / Ask
Bid?$3.59 × 100
Ask?$4.92 × 100
Spread?$1.33
Midpoint?$4.26
Valuation & Ratios
Market Cap?244.7M
Shares Out?59.4M
Float?33.8M
Float %?56.9%
P/E Ratio?N/A
P/B Ratio?-3.02
EPS?-$1.09
Dividend?0.00%
Ex-Dividend?N/A
News
Profile
Foghorn Therapeutics Inc is a clinical stage, precision therapeutics biotechnology company focused on pioneering a new class of medicines that treat serious diseases by correcting abnormal gene expression through selectively targeting the chromatin regulatory system. Its proprietary platform is designed to provide an integrated, mechanistic understanding of interactions within the chromatin regulatory system, supporting the identification and validation of potential therapeutic targets. The company's flagship program is FHD-909.
Themes
Biotech - Drug Development›Clinical-Stage PlatformsHealthcare - Genomics & Precision Medicine›Precision Medicine Platforms
Employees
106
Market Cap
244.7M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.foghorntx.com
Listed
2020-10-23
Address
500 TECHNOLOGY SQUARE
CAMBRIDGE, MA 02139
Phone: 617-586-3100
Technical OutlookStrong Sell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?▼ Bearish(-2/3)
Short-Term (Ripple)?– Neutral(0/3)
MA Alignment?Mixed
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
23
Z-Score?
0
Momentum?
75
Short Sent.?
64
Piotroski F-Score?3/9Weak
Altman Z-Score?-4.32Distress
Confidence?48%Low
Full Fundamental Analysis →
Short InterestElevated
Short % of Float?5.83%Elevated
Short Interest?2.0M
Days to Cover?4.6
Free Float33.8M
Avg Daily Volume424.6K
Settlement Date2026-08-31
Financial Health
Current Ratio?3.36Strong
Quick Ratio?3.36Strong
Cash Ratio?1.35Strong
Debt/Equity?-0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
83/100
P/E?
N/A▾
P/B?
S&P
97
-3.02CHEAP▾
P/S?
Peers
100
S&P
19
6.66FAIR▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-2.7CHEAP▾
EV/Sales?
Peers
100
S&P
38
4.81FAIR▾
Returns & Efficiency
ROE?
Peers
50
S&P
97
79.7%STRONG▾
ROA?
S&P
3
-31.8%WEAK▾
Cash Flow & Enterprise
FCF?$-84291000
Enterprise Value?$176.6M
Fundamentals ratios updated end of day
MarketsMoversWatchlist